We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Novel Cervical Cancer Screening Method to Reduce Need for Invasive Procedures

By LabMedica International staff writers
Posted on 06 Aug 2024

Cervical cancer remains a significant global health issue, with about 500,000 new cases identified annually. More...

The incidence of cervical intraepithelial neoplasia (CIN), or precursor lesions to cervical cancer, is even more common, occurring 20 times as frequently. Timely detection of these conditions is crucial for effective treatment and improved patient outcomes, underscoring the importance of advancing screening techniques for CIN and cervical cancer. The primary methods currently employed are the human papillomavirus (HPV) test and cytology examination. While cytology is a longstanding method with widespread use, its sensitivity for detecting CIN is relatively low. Conversely, while HPV tests are highly sensitive, they often lack specificity since not all HPV infections lead to cervical lesions. This underscores the pressing need for more refined diagnostic approaches.

Against this backdrop, researchers at Fujita Health University (Aichi, Japan) have been exploring biomarkers that could facilitate the early detection of cervical cancer. Their latest findings, published in Cancer Science, include identifying compounds with abnormal expressions in both serum and cervical mucus of patients with cervical cancer, potentially offering new avenues for disease prevention strategies. Originally, the study was intended to focus on serum-based diagnostics, but an exploration into the immune changes locally within the cervix shifted their focus to examining all the currently known microRNAs (miRNAs) involved in cervical cancer's development and progression. The shift led to an investigation into whether molecular expressions in local tissues were consistent with those in serum, to validate the potential for a serum-based diagnostic approach.

The team conducted comparative analyses of miRNA and cytokine profiles from both serum and mucus samples, collected over approximately eight years from patients undergoing routine gynecological exams who had either cervical cancer or CIN. Initial screenings identified three miRNAs and five cytokines in serum, and five miRNAs and seven cytokines in mucus as candidates. Subsequent testing using miRNA real-time PCR and cytokine immunoassays on a larger cohort confirmed these biomarkers' abnormal expressions at various stages of cervical cancer. In contrast to their initial expectations, while the serum biomarkers showed limited diagnostic accuracy, a combination of specific miRNAs and cytokines in the mucus samples demonstrated more promising diagnostic potential. The findings suggest that targeting local expression changes might provide a more effective diagnostic strategy than focusing on serum levels. However, further studies with larger sample sizes are needed to confirm these results and potentially lead to superior screening and diagnostic tools for cervical cancer. Such advancements could ultimately diminish the necessity for invasive procedures like colposcopy, alleviating patient discomfort and reducing healthcare costs.

“Our study, for the first time, demonstrates that analyzing mucus samples can distinguish cervical tumors from normal tissues more accurately than serum samples,” said Professor Takuma Fujii from Fujita Health University who led the research team. “Using such a method as an additional option to traditional screening techniques could help discover cancer and precancerous conditions at an earlier stage.”

Related Links:
Fujita Health University


New
Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Rapid Molecular Testing Device
FlashDetect Flash10
New
Gel Cards
DG Gel Cards
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.